Newsbenzinga
This Sonoco Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday
· Published
Article summary
Analysts downgraded Ultragenyx, Moderna and Sonoco; targets fell for RARE and SON but rose for MRNA.
An excerpt from the original article.
Comments —
Loading comments…